Cargando…
Development of Leishmania vaccines: predicting the future from past and present experience
Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement and fatal systemic infection. Resistance to infection is associated with a T-helper-1 immune response that activates macrophages to kill the intracellular parasite in a nitric oxide-dependent manner. Conver...
Autores principales: | Mutiso, Joshua Muli, Macharia, John Chege, Kiio, Maria Ndunge, Ichagichu, James Maina, Rikoi, Hitler, Gicheru, Michael Muita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602867/ https://www.ncbi.nlm.nih.gov/pubmed/23554800 http://dx.doi.org/10.7555/JBR.27.20120064 |
Ejemplares similares
-
Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops)()
por: Mutiso, Joshua Muli, et al.
Publicado: (2012) -
A review of adjuvants for Leishmania vaccine candidates
por: Mutiso, Joshua M., et al.
Publicado: (2010) -
Safety and Efficacy of Prosopis juliflora Leaf Extract as a Potential Treatment against Visceral Leishmaniasis in Balb/c Mice
por: Mutile, Muendo Charity, et al.
Publicado: (2021) -
Prosthetic urology: past, present, and future
por: Tsambarlis, Peter N, et al.
Publicado: (2019) -
The past, present, and future of single-port urology?
por: Morgantini, Luca A, et al.
Publicado: (2021)